Results for Autism Spectrum Disorder

Dr. Blum is the principal investigator for the national multi-site Developmental-Behavioral Pediatric Research Network (DBPNet). Recent studies in the network relate to the assessment and treatment of attention deficit/ hyperactivity disorder (ADHD) and of autism spectrum disorders (ASD).

Dr. Jackel is a developmental pediatrician with a strong focus on the evaluation and treatment of children with autism spectrum disorder (ASD). She works as a clinician on the MEG imaging studies for children with ASD.

Dr. Berman's research focuses on the coupling between brain structure and function and how abnormal development of the structure-function relationships contribute to the clinical symptoms of disorders such as autism spectrum disorder. 

Research by Dr. Yerys focuses on the development of cognitive and neural mechanisms that support adaptive behavior in children with neurodevelopmental disorders.

Lisa Blaskey, PhD, is a clinical neuropsychologist at the Center for Autism Research and the Lurie Family Foundations MEG Imaging Center. Dr. Blaskey serves as a co-investigator and clinical expert on ASD neuroimaging studies, designing clinical and neuropsychological phenotyping batteries.

Dr. Tunç is a computational scientist investigating the application of machine learning and statistical data analysis in various domains such as digital phenotyping, nature of psychopathology, and neuroimaging. He participates in studies using normative, developmental, and clinical samples to parse heterogeneity in psychiatric disorders by developing novel computational techniques.

Dr. Miller's research focuses on diagnostic and outcome issues, including differentiating autism from other genetic and psychiatric conditions, diagnostic and outcome studies across the lifespan, early identification and screening, and improving systems of care.

Dr. Shults works to develop statistical methods for longitudinal data that include semi-parametric approaches to account for subject/cluster level associations and maximum likelihood-based approaches for simulation and analysis of discrete longitudinal outcomes that may have overdispersion.

Dr. Roberts investigates brain-wave scanning with magnetoencephalography (MEG) and works to identify biomarkers for neuropsychiatric disorders like autism. Those biomarkers are for diagnosis, prognosis, stratification, and response monitoring as well as substrate identification for targeted therapy. Putting the "bio" into biomarkers is a major emphasis of Dr. Roberts' research, for which he uses advanced diffusion magnetic resonance imaging (MRI) and edited spectroscopy.